Neuronavigated robotic-enabled TMS: Clinical Trials

1 trial of Neuronavigated robotic-enabled TMS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Neuronavigated robotic-enabled TMS: new trials by email Literature Review of Neuronavigated robotic-enabled TMS trials Research Report on Neuronavigated robotic-enabled TMS

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
Neuronavigated robotic-enabled TMS, NRX-101, Sham TMS - Treatment Resistant Depression, Treatment Resistant Depression (TRD)
Phase 2 / Phase 3RecruitingNeuroRx, Inc.2402026-12-012026-10-21

Conditions studied

Depression (1)  ·  Depressive Disorder, Treatment-Resistant (1)

Sponsors

NeuroRx, Inc. (1)

Countries

United States (1)

Top investigators

Jonathan Javitt, MD, MPH (1)  ·  Joshua Brown, MD, PhD (1)